Anti-inflammatory drugs such as the nonsteroidal anti-inflammatory drugs (NSAID) can induce GDF15 expression [13], and VLDC can significantly reduce low-grade inflammation of type 2 diabetes mellitus patients [42]. This evidence concerns the gene GDF15 and diabetes mellitus.